Founded in 2016, ALS Investment Fund focuses on investing in biotech companies that develop drugs and diagnostics for Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease. They have a global investment strategy but primarily target companies in Europe and the US. With a deep understanding of the disease and a strong network in the industry, ALS Investment Fund aims to extend the life expectancy and potentially find a cure for ALS patients.